285 Warm Springs Rd Las Vegas, NV 89119
This exceptional owner-user opportunity presents two single-story, Class B office buildings totaling approximately 10,000 square feet on a 2.16-acre lot in Las Vegas, Nevada. Located at 285 E. Warm Springs Rd, this property boasts a highly desirable South Las Vegas location, offering convenient access to I-15/215, the airport connector, and the renowned Las Vegas Strip. The buildings, constructed in 2002, feature a tranquil courtyard setting and are currently vacant, with an occupancy date of May 14, 2024. The property is zoned C-P and offers the flexibility for either full building purchase or subdivision into smaller units. Building 285 can be divided into approximately 6,000 and 4,000 square foot spaces, while Building 295 can be divided into approximately 6,000 and 5,000 square foot spaces. The asking price is $3,450,000, translating to $345 per square foot. This presents a rare opportunity to acquire a substantial office complex in a thriving business district, surrounded by major corporations and medical facilities, including Fresenius Dialysis. The property's prime location and flexible layout make it ideal for a variety of professional or medical groups seeking a prestigious and easily accessible workspace. The property's APN is 177-09-513-005. The property consists of four units across two buildings.
-
Exquisite City Home Theater Electronics & Wireless Store
-
Republic Mortgage Wholesale Loan Service Bank
Cap rate
Implied · in-place · derived from last sale + estimated NOIValue
AI, CAP & Alternative Use estimations · Realmo proprietary blendComparables
6 recent transactions · within 1.5 miComparable in this City
Similar Nearby for Sale
Similar Nearby for Lease
Property description
Physical attributes from public recordsZoning & alternative use
No recorded transactions found for this property.
Costs & Benchmarks
Operating expenses, capex projections, utility benchmarks, and submarket comparables — all in one view.
Risks
Flood, climate, environmental, title, and tenant-concentration risk — surfaced with mitigations and source citations.